鶹ýӰ

Meeting Coverage

NKF

National Kidney Foundation

PROTECT Drugs Tied to Slower eGFR Decline vs Standard Care in IgA Nephropathy

Slower kidney function decline observed with sparsentan and irbesartan

NKF over a photo of Long Beach Convention and Entertainment Center, in Long Beach, CA

Latest NKF Meeting Coverage

Many Patients With CKD Never Receive a Diagnosis

These are people who are getting tested and seeing doctors, but still not getting diagnosed

May 19, 2024
Gastrointestinal Bleeding More Common in Advanced CKD

Risk was significantly higher regardless of dialysis status

May 19, 2024
Not All Nephrologists Measure Kidney Size in 'Adult' Polycystic Kidney Disease

Of those who do, 88% reported using the gold-standard imaging biomarker in determining prognosis

May 17, 2024
Sparsentan Bests Irbesartan for Rare, Progressive Kidney Disease

However, the FDA remains unconvinced that results support a new indication for the drug

May 17, 2024
Blood Disorder Drug Cuts Proteinuria in Rare Kidney Disorder

Reduced 24-hour UPCR by 38.3%

May 16, 2024
Draw Between Two Diuretics for Renal Prevention in Hypertension

But researcher questions if patients were underdosed

May 16, 2024
NKF Roundup: Latest Data on Tolvaptan, Terlipressin, and Lumasiran

More research from the National Kidney Foundation Spring Clinical Meeting

April 17, 2023
Nonimmunosuppressive Therapy Bests ARB for Cutting Proteinuira in IgA Nephropathy

Interim PROTECT data show nephroprotective potential of sparsentan

April 15, 2023
Common Diuretic Pauses Atherosclerosis in CKD, T2D

If finerenone isn't available, try spironolactone, said researcher

April 15, 2023
Low-Potassium Diet Not Enough to Stave off Recurrent Hyperkalemia

Consider adding a potassium binder to the mix, researcher suggests

April 14, 2023
Renal Function Safe With Pegloticase-MTX Combo for Gout

Analysis looked at patients with stage 1-3 CKD from the MIRROR trial

April 14, 2023
Another Measure of Terlipressin Success in Hepatorenal Syndrome

Goal of 30% reduction in serum creatinine in the absence of full response or HRS reversal

April 13, 2023
Long COVID Patients on Dialysis See Elevated Oxidative Stress Markers

Temporary vascular access, uncontrolled hypertension may be risk factors in this population

April 13, 2023
Novel Agents Promising in Pruritus, Rare Metabolic Disease, and More

A round-up of noteworthy research from the NKF Spring Clinical Meetings

April 10, 2022